Blocking STAT3/5 through Direct or Upstream Kinase Targeting in Leukemic Cutaneous T Cell Lymphoma

Scientists integrated genomic landscape analyses with innovative pharmacologic interference studies to identify key vulnerable nodes in leukemic cutaneous T cell lymphomas.